Plunkett's Biotech & Genetics Industry Almanac 2012: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies

Key Features: Industry trends analysis, market data and competitive intelligence Market forecasts and Industry Statistics Industry Associations and Professional Societies List InDepth Profiles of hundreds of leading companies Industry Glossary Buyer may register for access to search and export data at Plunkett Research Online A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms. You will gain vital insights that can help you shape your own strategy for business development, product development and investments. How is the industry evolving? How is the industry being shaped by new technologies? How is demand growing in emerging markets and mature economies? What is the size of the market now and in the future? What are the financial results of the leading companies? What are the names and titles of top executives? “One more fine example of the fine publications offered by Plunkett Research. This reference book is particularly timely given the considerable interest in biotech and genetics from scientific, investment and entrepreneurial audiences…Will be an excellent source for nearly any kind of library.” American Reference Books Annual The biotechnology field is finally beginning to blossom. Venture capital and private placement funding are supporting biotech firms, and scores of promising new drugs are in Phase I and Phase II clinical trials. Laboratories at leading universities are partnering with leading pharmaceuticals companies to push research and development along at faster levels. Meanwhile, nations such as China, India, Taiwan, South Korea and Singapore are fostering innovation with massive investments in new R&D centers of their own—some of which are focused on stem cell technology. The promise of personalized medicine is starting to come into fruition, with many types of personal genetic diagnostic services being offered. Also, geneticallymodified (GM) foods are benefiting from the development of agricultural biotechnology at leading suppliers. Biochemicals are starting to revolutionize the polymers and specialty chemicals sectors. And biodiesel and other biomass fuels are taking hold. This carefullyresearched data is a complete biotechnology and genetics market research and business intelligence tool; everything you need to know about the business of biotechnology, proteomics, stem cells, agricultural biotechnology, biopharmaceuticals and more. Our coverage includes biotechnology business trends analysis and genetics industry statistics. We also include a biotechnology business glossary and a listing of biotechnology industry contacts, such as industry associations and government agencies. Next, we profile hundreds of leading biotechnology companies, such as drug manufacturers, bioinformatics and genetics database providers, clinical trials companies and contract manufacturers—a broad range of biotech sector companies. Our company profiles include complete business descriptions and up to 27 executives by name and title. Plunkett’s Biotechnology & Genetics Industry data enables you to search, filter and view selected companies and leagues, and then to export selected company contact data, including executive names. This respected book covers competitive intelligence, market research and business analytics — everything you need to know about the biotech industry, trends technologies, finances and leading companies, including: 1. Market research, competitive intelligence and business analysis for all biotechnology business sectors 2. Analysis of trends in biotechnology and biopharmaceuticals research, development, clinical trials and regulatory affairs, including developments at the FDA. 3. Trends in biotechnology funding, M&A, joint ventures, California state funding and venture capital. 4. Trends in stem cells, regenerative medicine and cloning research and regulation. 5. Growing investments in biotechnology and stem cell research in such nations as India, China and Singapore. 6. Biotechnology business statistics, including information on patents and patenting. 7. Personalized medicine and genetic diagnostics. 8. Systems biology and synthetic biology. 9. The convergence of nanotechnology and biotechnology. 10. Profiles of leading biotech companies in the U.S., U.K., Europe, Asia and Canada. Whether you purchase the printed almanac or buy a subscription to the online edition, you will find a complete overview, industry analysis and market research tool in one superb, valuepriced package. We provide you with our famous industry trends analysis, statistical tables, and a glossary, along with a database of industry contacts including associations and professional societies. And you receive our proprietary, indepth profiles of hundreds of leading companies in all facets of this industry—public and private companies, U.S. and nonU.S. based. Electronic Access to Company Profiles: Our online data enables you to search, filter and view selected companies, and then export contact data into text or Excel, including executive names with titles, plus the company addresses and phone numbers. Contents, Statistics, Forecasts and Analysis Include: Major Trends Affecting the Biotech & Genetics Industry 1) The State of the Biotechnology Industry Today 2) A Short History of Biotechnology 3) Ethanol Production Soars, But U.S. Federal Subsidy in Question 4) Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms 5) From India to Singapore to China, Nations Compete Fiercely in Biotech Development 6) Clinical Trials and Medical Records Processing in India Spark Concerns 7) Gene Therapies and Patients’ Genetic Profiles Promise a Personalized Approach to Medicine 8) Breakthrough Drugs for Cancer Treatment—Many More Will Follow 9) Few New Blockbusters: Major Drug Patents Expire While Generic Sales Growth Continues 10) Biotech and Orphan Drugs Pick Up the Slack as Blockbuster Mainstream Drugs Age 11) Biogenerics (Followon Biologics) are in Limbo in the U.S. 12) Breakthrough New Drug Delivery Systems Evolve 13) Stem Cells: Multiple Sources Stem from New Technologies 14) U.S. Government Stance on Funding for New Stem Cell Research Unclear 15) Stem Cells: Therapeutic Cloning Techniques Advance 16) Stem Cells: A New Era of Regenerative Medicine Takes Shape 17) Nanotechnology Converges with Biotech 18) Agricultural Biotechnology Scores Breakthroughs but Causes Controversy/Selective Breeding Offers a Compromise 19) Focus on Vaccines 20) Technology Discussion: Genomics 21) Technology Discussion: Proteomics 22) Technology Discussion: Microarrays 23) Technology Discussion: DNA Chips 24) Technology Discussion: SNPs (Snips) 25) Technology Discussion: Combinatorial Chemistry 26) Technology Discussion: Synthetic Biology 27) Technology Discussion: Recombinant DNA 28) Technology Discussion: Polymerase Chain Reaction (PCR) Biotech & Genetics Industry Statistics 1) Biotech Industry Overview 2) The U.S. Drug Discovery & Approval Process 3) U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2010 4) U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals:19932009 5) Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2010 6) Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.: Fiscal Years 20092011 7) U.S. Exports & Imports of Pharmaceutical Products: 20061st Quarter 2011 8) U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: Selected Calendar Years, 20042019 9) U.S. Prescription Drug Expenditures: 19652019 10) Total U.S. Biotechnology Patents Granted per Year by Patent Class: 19772010 11) Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Year 20102012 12) Global Area of Biotech Crops by Country: 2010 13) Biologics & Biotechnology R&D, PhRMA Member Companies: 2009 14) Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 19752010 15) Sales By Geographic Area, PhRMA Member Companies: 2009 16) Domestic U.S. Biopharmaceutical R&D Breakdown, PhRMA Member Companies: 2009 17) Domestic Biopharmaceutical R&D Scientific, Professional & Technical Personnel by Function, PhRMA Member Companies: 2009 18) Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 19702010

Additional Information

Companies Profiled:

23ANDME INC
3SBIO INC
4SC AG
AASTROM BIOSCIENCES INC
ABAXIS INC
ABBOTT LABORATORIES
ACCELRYS INC
ACCESS PHARMACEUTICALS INC
ACTELION LTD
ADAMIS PHARMACEUTICALS CORPORATION
ADOLOR CORP
ADVANCED CELL TECHNOLOGY INC
ADVANCED LIFE SCIENCES HOLDINGS INC
ADVANSOURCE BIOMATERIALS CORPORATION
AEOLUS PHARMACEUTICALS INC
AETERNA ZENTARIS INC
AFFYMETRIX INC
AGENUS INC
AGILENT TECHNOLOGIES INC
AKORN INC
ALBANY MOLECULAR RESEARCH INC
ALCON INC
ALDAGEN INC
ALEXION PHARMACEUTICALS INC
ALIMERA SCIENCES INC
ALKERMES INC
ALLERGAN INC
ALLIANCE PHARMACEUTICAL CORP
ALLOS THERAPEUTICS INC
ALPHARMA ANIMAL HEALTH
ALSERES PHARMACEUTICALS INC
AMARIN CORPORATION PLC
AMGEN INC
AMPLIPHI BIOSCIENCES CORPORATION
AMYLIN PHARMACEUTICALS INC
AMYRIS BIOTECHNOLOGIES INC
ANACOR PHARMACEUTICALS INC
ANGIOTECH PHARMACEUTICALS INC
ANIKA THERAPEUTICS INC
APP PHARMACEUTICALS INC
APPLIED MOLECULAR EVOLUTION INC
APRICUS BIOSCIENCES INC
APTALIS PHARMA
ARADIGM CORPORATION
ARCADIA BIOSCIENCES INC
ARENA PHARMACEUTICALS INC
ARIAD PHARMACEUTICALS INC
ARQULE INC
ARRAY BIOPHARMA INC
ARRYX INC
ASTELLAS PHARMA INC
ASTRAZENECA CANADA
ASTRAZENECA PLC
AVANIR PHARMACEUTICALS
AVAX TECHNOLOGIES INC
AVI BIOPHARMA INC
AVIVA BIOSCIENCES CORP
BASF SE
BAUSCH & LOMB INC
BAXTER INTERNATIONAL INC
BAYER AG
BAYER CORP
BAYER HEALTHCARE PHARMACEUTICALS
BIND BIOSCIENCES INC
BIO RAD LABORATORIES INC
BIOANALYTICAL SYSTEMS INC
BIOCANCELL THERAPEUTICS INC
BIOCOMPATIBLES INTERNATIONAL LTD
BIOCRYST PHARMACEUTICALS INC
BIOGEN IDEC INC
BIOHEART INC
BIOMARIN PHARMACEUTICAL INC
BIOMET INC
BIONANOMATRIX
BIORELIANCE CORP
BIOSITE INC
BIOTIME INC
BRACHYTHERAPY SERVICES INC
BRISTOLMYERS SQUIBB CO
BURRILL & COMPANY
CALIPER LIFE SCIENCES INC
CAMBREX CORP
CANGENE BIOPHARMA INC
CANGENE CORP
CARACO PHARMACEUTICAL LABORATORIES LTD
CARDIOME PHARMA CORP
CARDIUM THERAPEUTICS INC
CEGEDIM SA
CELERA CORPORATION
CELGENE CORP
CELL THERAPEUTICS INC
CELLARTIS AB
CELLDEX THERAPEUTICS INC
CELLULAR DYNAMICS INTERNATIONAL
CELSCI CORPORATION
CELSIS INTERNATIONAL PLC
CEPHALON INC
CEPHEID
CERUS CORPORATION
CHARLES RIVER LABORATORIES
INTERNATIONAL INC
CLAROS DIAGNOSTICS INC
CML HEALTHCARE INC
COLUMBIA LABORATORIES INC
COMPLETE GENOMICS INC
COMPUGEN LTD
CORTEX PHARMACEUTICALS INC
COVANCE INC
COVIDIEN PLC
CRUCELL NV
CSL LIMITED
CUBIST PHARMACEUTICALS INC
CUMBERLAND PHARMACEUTICALS INC
CURIS INC
CYTRX CORPORATION
DAIICHI SANKYO CO LTD
DAINIPPON SUMITOMO PHARMA CO LTD
DECODE GENETICS LTD
DENDREON CORPORATION
DEPOMED INC
DIADEXUS INC
DISCOVERY LABORATORIES INC
DIVI'S LABORATORIES LIMITED
DMEDICAL INDUSTRIES LTD
DOW AGROSCIENCES LLC
DR REDDY'S LABORATORIES LIMITED
DSM PHARMACEUTICALS INC
DUPONT (E I DU PONT DE NEMOURS & CO)
DUPONT AGRICULTURE & NUTRITION
DURECT CORP
DUSA PHARMACEUTICALS INC
DYAX CORP
EISAI CO LTD
ELAN CORP PLC
ELI LILLY & COMPANY
EMISPHERE TECHNOLOGIES INC
ENCORIUM GROUP INC
ENDO PHARMACEUTICALS HOLDINGS INC
ENTREMED INC
ENZO BIOCHEM INC
ENZON PHARMACEUTICALS INC
ERESEARCH TECHNOLOGY INC
EUSA PHARMA (USA) INC
EVOTEC AG
EXELIXIS INC
FLAMEL TECHNOLOGIES SA
FOREST LABORATORIES INC
GALDERMA PHARMA SA
GE HEALTHCARE
GENENCOR INTERNATIONAL INC
GENENTECH INC
GENEREX BIOTECHNOLOGY CORPORATION
GENMARK DIAGNOSTICS INC
GENOMIC HEALTH INC
GENPROBE INC
GENTA INC
GENVEC INC
GENZYME BIOSURGERY
GENZYME CORP
GENZYME ONCOLOGY
GERON CORPORATION
GILEAD SCIENCES INC
GLAXOSMITHKLINE PLC
GTC BIOTHERAPEUTICS INC
HARBOR BIOSCIENCES INC
HARVARD BIOSCIENCE INC
HEMAGEN DIAGNOSTICS INC
HEMISPHERX BIOPHARMA INC
HESKA CORP
HITECH PHARMACAL CO INC
HOSPIRA INC
HUMAN GENOME SCIENCES INC
HYCOR BIOMEDICAL INC
I3 CANREG INC
ICON PLC
IDERA PHARMACEUTICALS INC
IDEXX LABORATORIES INC
ILLUMINA INC
IMCLONE SYSTEMS INC
IMMTECH PHARMACEUTICALS INC
IMMUCELL CORPORATION
IMMUNOGEN INC
IMMUNOMEDICS INC
IMPAX LABORATORIES INC
IMS HEALTH INC
INCYTE CORP
INFINITY PHARMACEUTICALS INC
INSITE VISION INC
INSMED INC
INSTITUT STRAUMANN AG
INTEGRA LIFESCIENCES HOLDINGS CORP
INTELLIPHARMACEUTICS INTERNATIONAL INC
INTERMUNE INC
INTERNATIONAL ISOTOPES INC
ION TORRENT
IRONWOOD PHARMACEUTICALS INC
ISIS PHARMACEUTICALS INC
JAZZ PHARMACEUTICALS INC
JOHNSON & JOHNSON
JOULE UNLIMITED TECHNOLOGIES
JUBILANT BIOSYS LTD
KENDLE INTERNATIONAL INC
KERYX BIOPHARMACEUTICALS INC
KV PHARMACEUTICAL CO
LA JOLLA PHARMACEUTICAL COMPANY
LANNETT COMPANY INC
LEXICON PHARMACEUTICALS INC
LIFE SCIENCES RESEARCH INC
LIFE TECHNOLOGIES CORP
LIFECELL CORPORATION
LIFECORE BIOMEDICAL INC
LIGAND PHARMACEUTICALS INC
LONZA GROUP
LORUS THERAPEUTICS INC
LUMINEX CORPORATION
MANHATTAN PHARMACEUTICALS INC
MARINA BIOTECH
MAXYGEN INC
MEDICINES CO (THE)
MEDICIS PHARMACEUTICAL CORP
MEDIDATA SOLUTIONS INC
MEDIMMUNE INC
MEDTOX SCIENTIFIC INC
MERCK & CO INC
MERCK KGAA
MERCK SERONO SA
MERIDIAN BIOSCIENCE INC
METABOLIX INC
MILLENNIUM PHARMACEUTICALS INC
MILLIPORE CORP
MONSANTO CO
MYLAN INC
MYRIAD GENETICS INC
MYRIAD RBM
NABI BIOPHARMACEUTICALS
NANOBIO CORPORATION
NEKTAR THERAPEUTICS
NEOGEN CORPORATION
NEOPROBE CORPORATION
NORDION INC
NOVARTIS AG
NOVAVAX INC
NOVEN PHARMACEUTICALS INC
NOVONORDISK AS
NOVOZYMES
NPS PHARMACEUTICALS INC
NYCOMED
OBAGI MEDICAL PRODUCTS INC
ONCOGENEX PHARMACEUTICALS
ONCOTHYREON INC
ONYX PHARMACEUTICALS INC
ORASURE TECHNOLOGIES INC
ORCHID CELLMARK INC
ORE HOLDINGS INC
ORGANOGENESIS INC
OSI PHARMACEUTICALS LLC
OTSUKA HOLDINGS CO LTD
OXIGENE INC
PACIFIC BIOMARKERS INC
PACIFIC BIOSCIENCES OF CALIFORNIA INC
PAIN THERAPEUTICS INC
PALATIN TECHNOLOGIES INC
PAR PHARMACEUTICAL COMPANIES INC
PAREXEL INTERNATIONAL CORP
PDL BIOPHARMA
PEREGRINE PHARMACEUTICALS INC
PERRIGO CO
PFIZER INC
PHARMACEUTICAL PRODUCT DEVELOPMENT INC
PHARMACYCLICS INC
PHARMANET DEVELOPMENT GROUP INC
PHARMATHENE INC
PHARMOS CORP
PHARSIGHT CORP
PIONEER HIBRED INTERNATIONAL INC
POLYDEX PHARMACEUTICALS LTD
PONIARD PHARMACEUTICALS INC
POZEN INC
PRA INTERNATIONAL
PROGENICS PHARMACEUTICALS INC
PROMEGA CORP
PROTEIN POLYMER TECHNOLOGIES INC
QIAGEN NV
QLT INC
QUEST DIAGNOSTICS INC
QUESTCOR PHARMACEUTICALS INC
QUINTILES TRANSNATIONAL CORP
RANBAXY LABORATORIES LIMITED
RAPTOR PHARMACEUTICAL CORP
REGENERON PHARMACEUTICALS INC
REPLIGEN CORPORATION
REPROS THERAPEUTICS INC
RIGEL PHARMACEUTICALS INC
ROCHE HOLDING LTD
S&W SEED CO
SALIX PHARMACEUTICALS
SANGAMO BIOSCIENCES INC
SANOFIAVENTIS SA
SAVIENT PHARMACEUTICALS INC
SCICLONE PHARMACEUTICALS INC
SCIOS INC
SEATTLE GENETICS
SENETEK PLC
SEQUENOM INC
SERACARE LIFE SCIENCES INC
SHIONOGI INC
SHIRE CANADA INC
SHIRE PLC
SIEMENS HEALTHCARE DIAGNOSTICS
SIGA TECHNOLOGIES INC
SIGMAALDRICH CORP
SIMCERE PHARMACEUTICAL GROUP
SKYEPHARMA PLC
SOLIGENIX INC
SPECIALTY LABORATORIES INC
SPECTRAL DIAGNOSTICS INC
SPECTRUM PHARMACEUTICALS INC
SPHERIX INC
STEMCELLS INC
STIEFEL LABORATORIES INC
SUPERGEN INC
SYNBIOTICS CORP
SYNGENTA AG
SYNOVIS LIFE TECHNOLOGIES INC
SYNTHETIC GENOMICS
TAKEDA PHARMACEUTICAL COMPANY LTD
TAMIR BIOTECHNOLOGY INC
TARO PHARMACEUTICAL INDUSTRIES
TECHNE CORP
TELIK INC
TENGION INC
TEVA PARENTERAL MEDICINES INC
TEVA PHARMACEUTICAL INDUSTRIES LTD
THERAGENICS CORP
THERMO FISHER SCIENTIFIC INC
THERMO SCIENTIFIC
TITAN PHARMACEUTICALS INC
TOLMAR INC
TOYOBO CO LTD
TRIMERIS INC
TRINITY BIOTECH PLC
TRIPOS INTERNATIONAL
TRIUS THERAPEUTICS INC
UCB SA
UNIGENE LABORATORIES INC
UNITED THERAPEUTICS CORP
UNITEDGUARDIAN INC
URIGEN PHARMACEUTICALS INC
VALEANT PHARMACEUTICALS INTERNATIONAL
VENTRIA BIOSCIENCE
VERENIUM CORPORATION
VERMILLION INC
VERNALIS PLC
VERTEX PHARMACEUTICALS INC
VIACORD INC
VICAL INC
VIRBAC CORP
VIROPHARMA INC
VIVUS INC
WARNER CHILCOTT PLC
WATSON PHARMACEUTICALS INC
WHATMAN PLC
XDX INC
XECHEM INTERNATIONAL
XENOPORT INC
XOMA LTD
ZIOPHARM ONCOLOGY INC
ZOGENIX INC
ZYMOGENETICS INC

Key Biotechnology, Drugs & Genetics Industry Topics:

• Biopharmaceuticals
• Genetically Modified (GM) Foods and Bioagriculture (AGRIBIO)
• Diagnostics
• FDA
• Personalized Medicine
• Systems Biology
• Regulation
• Research and Development (R&D)
• Stem Cells
• Cloning
• Drug Discovery
• Clinical Trials
• Bioanalysis
• Partnerships
• Funding Distribution
• Profiles of Leading Biotechnology Companies
• Executive Mailing Lists